文献速递糖尿病肥胖与代谢综合征

GLP-1受体激动剂与替尔泊肽延迟胃排空的临床后果

Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

本文综述GLP-1受体激动剂(GLP-1RA)及替尔泊肽因延缓胃排空和小肠动力而带来的临床后果。上消化道内镜时胃内容物残留更常见于GLP-1RA使用者,但极少与肺误吸相关;围手术期管理建议因证据有限而受限。延长固体食物禁食时间、床旁超声评估胃内容物及使用促动力药如红霉素可能有益,是需进一步研究的重要领域。

要点

  • GLP-1RA治疗与上消化道内镜时胃内容物残留更常见相关,但极少与肺误吸相关。
  • 围手术期GLP-1RA管理建议(是否停药及停药时长)因证据有限而受限。
  • 延长固体食物禁食、床旁超声评估胃内容物及促动力药如红霉素可能有益。

核心结论

  • 延长固体食物禁食时间、床旁超声检查胃内容物及使用促动力药如红霉素可能有益,是需进一步研究以提高GLP-1RA治疗患者安全性的重要领域。

研究设计与样本

  • 检索PubMed数据库纳入涉及GLP-1RA治疗与不良胃肠道/胆道事件的研究进行综述。

主要发现

  • 上消化道内镜时胃内容物残留更常见于GLP-1RA使用者,但极少与肺误吸相关。
  • 围手术期GLP-1RA管理(如是否停药及停药时长)的合理建议因证据有限而受限。
  • 需考虑的重要因素包括:GLP-1RA半衰期长、GLP-1受体激动在生理浓度下即可延缓胃排空、长期治疗可见快速耐受、以及治疗前已有胃排空延迟者效果有限。
  • 关于糖尿病本身(无GLP-1RA治疗时)对胃内容物残留和肺误吸影响的信息很少。

临床怎么用

  • 延长固体食物禁食时间可能有益。
  • 床旁超声检查胃内容物可能有益。
  • 使用促动力药如红霉素可能有益。

局限性

  • 围手术期GLP-1RA管理建议因证据有限而受限。
  • 关于糖尿病本身(无GLP-1RA治疗时)对胃内容物残留和肺误吸影响的信息很少。
  • 延长固体食物禁食、床旁超声及促动力药等措施是需进一步研究的重要领域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) are established therapeutics for type 2 diabetes and obesity. Among other mechanisms, they slow gastric emptying and motility of the small intestine. This helps to limit postprandial glycemic excursions and reduce chylomicron formation and triglyceride absorption. Conversely, motility effects may have detrimental consequences, eg, retained gastric contents at endoscopy or general anesthesia, potentially complicated by pulmonary aspiration or bowel obstruction. DATA ACQUISITION: We searched the PubMed database for studies involving GLP-1RA therapy and adverse gastrointestinal/biliary events. DATA SYNTHESIS: Retained gastric contents at the time of upper gastrointestinal endoscopy are found more frequently with GLP-1 RAs but rarely are associated with pulmonary aspiration. Well-justified recommendations for the periprocedural management of GLP-1RAs (eg, whether to withhold these medications and for how long) are compromised by limited evidence. Important aspects to be considered are (1) their long half-lives, (2) the capacity of GLP-1 receptor agonism to slow gastric emptying even at physiological GLP-1 concentrations, (c) tachyphylaxis observed with prolonged treatment, and (d) the limited effect on gastric emptying in individuals with slow gastric emptying before initiating treatment. Little information is available on the influence of diabetes mellitus itself (ie, in the absence of GLP-1 RA treatment) on retained gastric contents and pulmonary aspiration. CONCLUSION: Prolonged fasting periods regarding solid meal components, point-of-care ultrasound examination for retained gastric content, and the use of prokinetic medications like erythromycin may prove helpful and represent an important area needing further study to increase patient safety for those treated with GLP-1 RAs.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Jalleh RJ, Plummer MP, Marathe CS, et al. Clinical Consequences of Delayed Gastric Emptying With GLP-1 Receptor Agonists and Tirzepatide. J Clin Endocrinol Metab. 2024. PMID: 39418085. doi:10.1210/clinem/dgae719

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。